| UniProt ID | FND3B_HUMAN | |
|---|---|---|
| UniProt AC | Q53EP0 | |
| Protein Name | Fibronectin type III domain-containing protein 3B | |
| Gene Name | FNDC3B | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1204 | |
| Subcellular Localization |
Membrane Single-pass membrane protein. |
|
| Protein Description | May be a positive regulator of adipogenesis.. | |
| Protein Sequence | MYVTMMMTDQIPLELPPLLNGEVAMMPHLVNGDAAQQVILVQVNPGETFTIRAEDGTLQCIQGPAEVPMMSPNGSIPPIHVPPGYISQVIEDSTGVRRVVVTPQSPECYPPSYPSAMSPTHHLPPYLTHHPHFIHNSHTAYYPPVTGPGDMPPQFFPQHHLPHTIYGEQEIIPFYGMSTYITREDQYSKPPHKKLKDRQIDRQNRLNSPPSSIYKSSCTTVYNGYGKGHSGGSGGGGSGSGPGIKKTERRARSSPKSNDSDLQEYELEVKRVQDILSGIEKPQVSNIQARAVVLSWAPPVGLSCGPHSGLSFPYSYEVALSDKGRDGKYKIIYSGEELECNLKDLRPATDYHVRVYAMYNSVKGSCSEPVSFTTHSCAPECPFPPKLAHRSKSSLTLQWKAPIDNGSKITNYLLEWDEGKRNSGFRQCFFGSQKHCKLTKLCPAMGYTFRLAARNDIGTSGYSQEVVCYTLGNIPQMPSAPRLVRAGITWVTLQWSKPEGCSPEEVITYTLEIQEDENDNLFHPKYTGEDLTCTVKNLKRSTQYKFRLTASNTEGKSCPSEVLVCTTSPDRPGPPTRPLVKGPVTSHGFSVKWDPPKDNGGSEILKYLLEITDGNSEANQWEVAYSGSATEYTFTHLKPGTLYKLRACCISTGGHSQCSESLPVRTLSIAPGQCRPPRVLGRPKHKEVHLEWDVPASESGCEVSEYSVEMTEPEDVASEVYHGPELECTVGNLLPGTVYRFRVRALNDGGYGPYSDVSEITTAAGPPGQCKAPCISCTPDGCVLVGWESPDSSGADISEYRLEWGEDEESLELIYHGTDTRFEIRDLLPAAQYCCRLQAFNQAGAGPYSELVLCQTPASAPDPVSTLCVLEEEPLDAYPDSPSACLVLNWEEPCNNGSEILAYTIDLGDTSITVGNTTMHVMKDLLPETTYRIRIQAINEIGAGPFSQFIKAKTRPLPPLPPRLECAAAGPQSLKLKWGDSNSKTHAAEDIVYTLQLEDRNKRFISIYRGPSHTYKVQRLTEFTCYSFRIQAASEAGEGPFSETYTFSTTKSVPPTIKAPRVTQLEGNSCEILWETVPSMKGDPVNYILQVLVGRESEYKQVYKGEEATFQISGLQTNTDYRFRVCACRRCLDTSQELSGAFSPSAAFVLQRSEVMLTGDMGSLDDPKMKSMMPTDEQFAAIIVLGFATLSILFAFILQYFLMK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 50 | Phosphorylation | VNPGETFTIRAEDGT ECCCCEEEEEECCCC | 19.57 | 24719451 | |
| 175 | Phosphorylation | EQEIIPFYGMSTYIT CCEEEEECCCEEEEC | 13.43 | - | |
| 180 | Phosphorylation | PFYGMSTYITREDQY EECCCEEEECCHHHC | 7.93 | - | |
| 208 | Phosphorylation | DRQNRLNSPPSSIYK HHHHCCCCCCHHHHH | 42.66 | 19664994 | |
| 211 | Phosphorylation | NRLNSPPSSIYKSSC HCCCCCCHHHHHCCC | 32.52 | 30266825 | |
| 212 | Phosphorylation | RLNSPPSSIYKSSCT CCCCCCHHHHHCCCE | 35.39 | 30266825 | |
| 214 | Phosphorylation | NSPPSSIYKSSCTTV CCCCHHHHHCCCEEE | 13.53 | - | |
| 215 | Methylation | SPPSSIYKSSCTTVY CCCHHHHHCCCEEEE | 33.93 | - | |
| 220 | Phosphorylation | IYKSSCTTVYNGYGK HHHCCCEEEECCCCC | 25.89 | 28985074 | |
| 222 | Phosphorylation | KSSCTTVYNGYGKGH HCCCEEEECCCCCCC | 10.77 | - | |
| 225 | Phosphorylation | CTTVYNGYGKGHSGG CEEEECCCCCCCCCC | 16.42 | 28985074 | |
| 227 | Ubiquitination | TVYNGYGKGHSGGSG EEECCCCCCCCCCCC | 44.99 | 29967540 | |
| 227 | Methylation | TVYNGYGKGHSGGSG EEECCCCCCCCCCCC | 44.99 | - | |
| 227 | Acetylation | TVYNGYGKGHSGGSG EEECCCCCCCCCCCC | 44.99 | 26051181 | |
| 230 | Phosphorylation | NGYGKGHSGGSGGGG CCCCCCCCCCCCCCC | 54.22 | 27251275 | |
| 233 | Phosphorylation | GKGHSGGSGGGGSGS CCCCCCCCCCCCCCC | 37.48 | 25159151 | |
| 238 | Phosphorylation | GGSGGGGSGSGPGIK CCCCCCCCCCCCCCC | 32.82 | 25159151 | |
| 240 | Phosphorylation | SGGGGSGSGPGIKKT CCCCCCCCCCCCCCC | 43.44 | 27251275 | |
| 245 | Ubiquitination | SGSGPGIKKTERRAR CCCCCCCCCCHHHHH | 60.60 | 29967540 | |
| 253 | Phosphorylation | KTERRARSSPKSNDS CCHHHHHCCCCCCCH | 50.43 | 23401153 | |
| 254 | Phosphorylation | TERRARSSPKSNDSD CHHHHHCCCCCCCHH | 30.69 | 27422710 | |
| 256 | Ubiquitination | RRARSSPKSNDSDLQ HHHHCCCCCCCHHHH | 64.93 | 29967540 | |
| 257 | Phosphorylation | RARSSPKSNDSDLQE HHHCCCCCCCHHHHH | 49.61 | 23403867 | |
| 260 | Phosphorylation | SSPKSNDSDLQEYEL CCCCCCCHHHHHHHH | 44.46 | 23403867 | |
| 265 | Phosphorylation | NDSDLQEYELEVKRV CCHHHHHHHHHHHHH | 16.92 | 28796482 | |
| 270 | Ubiquitination | QEYELEVKRVQDILS HHHHHHHHHHHHHHH | 37.16 | 29967540 | |
| 351 | Phosphorylation | DLRPATDYHVRVYAM HCCCCCCCEEEEEEE | 9.62 | - | |
| 359 | Phosphorylation | HVRVYAMYNSVKGSC EEEEEEEECCCCCCC | 8.98 | - | |
| 391 | Phosphorylation | PPKLAHRSKSSLTLQ CCCCCCCCCCCEEEE | 27.33 | 28857561 | |
| 393 | Phosphorylation | KLAHRSKSSLTLQWK CCCCCCCCCEEEEEE | 31.65 | 23403867 | |
| 394 | Phosphorylation | LAHRSKSSLTLQWKA CCCCCCCCEEEEEEE | 29.16 | 23403867 | |
| 396 | Phosphorylation | HRSKSSLTLQWKAPI CCCCCCEEEEEEEEC | 20.89 | 23403867 | |
| 407 | Phosphorylation | KAPIDNGSKITNYLL EEECCCCCCEEEEEE | 27.43 | - | |
| 408 | Ubiquitination | APIDNGSKITNYLLE EECCCCCCEEEEEEE | 55.75 | 29967540 | |
| 420 | Ubiquitination | LLEWDEGKRNSGFRQ EEEECCCCCCCCCHH | 46.49 | - | |
| 469 | Phosphorylation | YSQEVVCYTLGNIPQ CCCEEEEEEECCCCC | 8.06 | - | |
| 492 | Phosphorylation | RAGITWVTLQWSKPE HCCCEEEEEEECCCC | 12.56 | - | |
| 496 | Phosphorylation | TWVTLQWSKPEGCSP EEEEEEECCCCCCCH | 25.93 | 22496350 | |
| 532 | Phosphorylation | KYTGEDLTCTVKNLK CCCCCCCEEEEEECC | 20.60 | - | |
| 536 | Acetylation | EDLTCTVKNLKRSTQ CCCEEEEEECCCCCE | 38.11 | 26051181 | |
| 536 | Ubiquitination | EDLTCTVKNLKRSTQ CCCEEEEEECCCCCE | 38.11 | 29967540 | |
| 536 | Malonylation | EDLTCTVKNLKRSTQ CCCEEEEEECCCCCE | 38.11 | 26320211 | |
| 541 | Phosphorylation | TVKNLKRSTQYKFRL EEEECCCCCEEEEEE | 20.48 | - | |
| 568 | Phosphorylation | EVLVCTTSPDRPGPP CEEEEECCCCCCCCC | 13.47 | 25627689 | |
| 581 | Ubiquitination | PPTRPLVKGPVTSHG CCCCCCCCCCCCCCC | 66.24 | 29967540 | |
| 607 | Phosphorylation | GGSEILKYLLEITDG CHHHHHHHHEECCCC | 17.05 | 22817900 | |
| 625 | Phosphorylation | ANQWEVAYSGSATEY HCEEEEEEECCCCEE | 20.81 | 22817900 | |
| 632 | Phosphorylation | YSGSATEYTFTHLKP EECCCCEEEEEECCC | 11.64 | 22817900 | |
| 815 | Phosphorylation | EESLELIYHGTDTRF HHHEEEEEECCCCCE | 13.56 | 27642862 | |
| 951 | Ubiquitination | GPFSQFIKAKTRPLP CCHHHHHHHCCCCCC | 45.15 | - | |
| 953 | Ubiquitination | FSQFIKAKTRPLPPL HHHHHHHCCCCCCCC | 39.81 | - | |
| 975 | Malonylation | AAGPQSLKLKWGDSN CCCCCCEEEEECCCC | 53.95 | 26320211 | |
| 977 | Ubiquitination | GPQSLKLKWGDSNSK CCCCEEEEECCCCCC | 47.76 | 29967540 | |
| 1014 | Phosphorylation | IYRGPSHTYKVQRLT EEECCCCEEEEEEEC | 29.40 | - | |
| 1051 | Ubiquitination | TYTFSTTKSVPPTIK EEEEECCCCCCCCCC | 49.93 | - | |
| 1056 | Phosphorylation | TTKSVPPTIKAPRVT CCCCCCCCCCCCCEE | 29.10 | - | |
| 1063 | Phosphorylation | TIKAPRVTQLEGNSC CCCCCCEEEECCCCE | 28.81 | 29759185 | |
| 1103 | Phosphorylation | ESEYKQVYKGEEATF HHHCEEEECCCCEEE | 15.69 | - | |
| 1104 | Ubiquitination | SEYKQVYKGEEATFQ HHCEEEECCCCEEEE | 62.07 | - | |
| 1121 | Phosphorylation | GLQTNTDYRFRVCAC CCCCCCCCEEEEEEE | 15.04 | - | |
| 1134 | Phosphorylation | ACRRCLDTSQELSGA EEHHHHCCCCHHCCC | 21.25 | 29970186 | |
| 1143 | Phosphorylation | QELSGAFSPSAAFVL CHHCCCCCCCHHHEE | 19.87 | 29970186 | |
| 1145 | Phosphorylation | LSGAFSPSAAFVLQR HCCCCCCCHHHEECC | 30.91 | 29970186 | |
| 1153 | Phosphorylation | AAFVLQRSEVMLTGD HHHEECCCEEEEECC | 22.91 | - | |
| 1158 | Phosphorylation | QRSEVMLTGDMGSLD CCCEEEEECCCCCCC | 17.03 | - | |
| 1163 | Phosphorylation | MLTGDMGSLDDPKMK EEECCCCCCCCHHHH | 23.22 | 18669648 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FND3B_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FND3B_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FND3B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PCH2_HUMAN | TRIP13 | physical | 21516116 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-208 AND SER-1163, ANDMASS SPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-208 AND SER-211, ANDMASS SPECTROMETRY. | |